title: Selective potentiation of crossed vs. uncrossed inputs from lateral geniculate nucleus to visual cortex by the basal forebrain: potential facilitation of rodent binocularity.
abstract: Cholinergic projections originating in the basal forebrain (BF) play important roles in the heterosynaptic facilitation of synaptic strength in various sensory cortices, including the primary visual cortex (V1). Here, using urethane-anesthetized rats, we find that pairing burst stimulation of the BF with single pulse stimulation of the lateral geniculate nucleus (LGN) does not consistently increase field postsynaptic potentials (fPSPs) in V1 elicited by ipsilateral LGN stimulation. However, longer latency fPSPs recorded in V1 in response to stimulation of the contralateral LGN, reflecting crossed, polysynaptic inputs, show significant potentiation when paired with preceding BF stimulation. This synaptic enhancement requires relatively short time intervals between paired BF burst and LGN pulse stimulation (40 ms) and is abolished by systemic or local V1 muscarinic receptor blockade (scopolamine), while systemic nicotinic receptor blockade (mecamylamine) is ineffective. Together, these data provide evidence for a differential capacity for cholinergic/muscarinic-dependent plasticity induction among different signals in V1, with inputs reaching V1 from the contralateral LGN exhibiting potentiation in the face of stable strength in ipsilateral LGN-V1 projections. This preferential readiness for potentiation in crossed fiber systems could serve to amplify binocular responses in V1 elicited by synchronized excitation of ipsi- and contralateral LGN neurons.
authors.affiliation: Centre for Neuroscience Studies, Queen's University, Kingston, Ontario K7L 3N6, Canada.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Gagolewicz
authors.forename: Hans C
authors.initials: HC
authors.lastname: Dringenberg
mesh_terms: D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D004558:Electric Stimulation; D005829:Geniculate Bodies / Q000502:physiology*; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D018727:Muscarinic Antagonists / Q000494:pharmacology; D009473:Neuronal Plasticity; D018733:Nicotinic Antagonists / Q000494:pharmacology; D016548:Prosencephalon / Q000502:physiology*; D051381:Rats; D020318:Rats, Long-Evans; D012601:Scopolamine / Q000494:pharmacology; D013569:Synapses / Q000502:physiology; D055366:Synaptic Potentials; D015348:Vision, Binocular / Q000502:physiology*; D014793:Visual Cortex / Q000502:physiology
chemical_list: D018727:Muscarinic Antagonists; D018733:Nicotinic Antagonists; D008464:Mecamylamine; D012601:Scopolamine; D000109:Acetylcholine